Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2025-12-25 @ 10:16 PM
NCT ID: NCT01818258
Description: Serious Adverse Event (SAE) Reporting Category \[v2.0 of the DAIDS expedited adverse event Manual\] was used. Study agents for which relationship assessments were required: ZDV, 3TC, LPV/r and abacavir. Other events reported in an expedited fashion included malignancies, seizures and Grade 3/4 hepatotoxicities, and Grade 3/4 related toxicities where a relationship to study drug could not be ruled out. Events were summarized if onset was on or after entry.
Frequency Threshold: 5
Time Frame: From study entry to study completion at Week 48 or premature study discontinuation
Study: NCT01818258
Study Brief: IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Severe Malnutrition Severe Acute Malnutrition at Entry ZDV+3TC+LPV/r 3 None 9 25 25 25 View
Normal Nutrition/Mild Malnutrition Normal Nutrition or Mild Malnutrition at Entry ZDV+3TC+LPV/r 0 None 5 27 25 27 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Anaemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 21.1 View
Neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 21.1 View
Gastrointestinal haemorrhage SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 21.1 View
Gastroenteritis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.1 View
Pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.1 View
Pulmonary tuberculosis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.1 View
Haemoglobin decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 21.1 View
Neutrophil count decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 21.1 View
Malnutrition SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 21.1 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Blood triglycerides increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 21.1 View
Haemoglobin decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 21.1 View
Neutrophil count decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 21.1 View
Platelet count decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 21.1 View
Weight decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 21.1 View
Decreased appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 21.1 View
Dehydration SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 21.1 View
Failure to thrive SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 21.1 View
Malnutrition SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 21.1 View
Poor feeding infant SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 21.1 View
Underweight SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 21.1 View
Selective eating disorder SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 21.1 View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 21.1 View
Dyspnoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 21.1 View
Rales SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 21.1 View
Rhinorrhoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 21.1 View
Sneezing SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 21.1 View
Tachypnoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 21.1 View
Use of accessory respiratory muscles SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 21.1 View
Alopecia SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 21.1 View
Erythema SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 21.1 View
Papule SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 21.1 View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 21.1 View
Rash generalised SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 21.1 View
Rash papular SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 21.1 View
Pallor SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA 21.1 View
Stomatitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 21.1 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 21.1 View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders MedDRA 21.1 View
Conjunctivitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.1 View
Gastroenteritis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.1 View
Impetigo SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.1 View
Oral candidiasis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.1 View
Otitis media acute SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.1 View
Plasmodium falciparum infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.1 View
Pneumonia bacterial SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.1 View
Tinea faciei SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.1 View
Upper respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.1 View
Alanine aminotransferase increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 21.1 View
Aspartate aminotransferase increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 21.1 View
Blood albumin decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 21.1 View
Blood bicarbonate decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 21.1 View
Blood cholesterol increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 21.1 View
Blood glucose decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 21.1 View
Blood glucose increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 21.1 View
Blood potassium decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 21.1 View
Blood potassium increased SYSTEMATIC_ASSESSMENT Investigations MedDRA 21.1 View
Blood sodium decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA 21.1 View
Splenomegaly SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 21.1 View
Oral disorder SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 21.1 View
Anaemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 21.1 View
Iron deficiency anaemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 21.1 View
Lymphadenopathy SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 21.1 View
Otorrhoea SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders MedDRA 21.1 View
Tympanic membrane hyperaemia SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders MedDRA 21.1 View
Eye discharge SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 21.1 View
Ocular hyperaemia SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 21.1 View
Abdominal distension SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 21.1 View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 21.1 View